Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2012 Dec 1;35(12):1593-602.
doi: 10.5665/sleep.2226.

Effects of continuous positive airway pressure on neurocognitive function in obstructive sleep apnea patients: The Apnea Positive Pressure Long-term Efficacy Study (APPLES)

Clete A Kushida  1 , Deborah A Nichols, Tyson H Holmes, Stuart F Quan, James K Walsh, Daniel J Gottlieb, Richard D Simon Jr, Christian Guilleminault, David P White, James L Goodwin, Paula K Schweitzer, Eileen B Leary, Pamela R Hyde, Max Hirshkowitz, Sylvan Green, Linda K McEvoy, Cynthia Chan, Alan Gevins, Gary G Kay, Daniel A Bloch, Tami Crabtree, William C Dement
Affiliations
Randomized Controlled Trial

Effects of continuous positive airway pressure on neurocognitive function in obstructive sleep apnea patients: The Apnea Positive Pressure Long-term Efficacy Study (APPLES)

Clete A Kushida et al. Sleep. .

Erratum in

  • Erratum.
    [No authors listed] [No authors listed] Sleep. 2016 Jul 1;39(7):1483. doi: 10.5665/sleep.5988. Sleep. 2016. PMID: 31265514 Free PMC article.

Abstract

Study objective: To determine the neurocognitive effects of continuous positive airway pressure (CPAP) therapy on patients with obstructive sleep apnea (OSA).

Design, setting, and participants: The Apnea Positive Pressure Long-term Efficacy Study (APPLES) was a 6-month, randomized, double-blind, 2-arm, sham-controlled, multicenter trial conducted at 5 U.S. university, hospital, or private practices. Of 1,516 participants enrolled, 1,105 were randomized, and 1,098 participants diagnosed with OSA contributed to the analysis of the primary outcome measures.

Intervention: Active or sham CPAP MEASUREMENTS: THREE NEUROCOGNITIVE VARIABLES, EACH REPRESENTING A NEUROCOGNITIVE DOMAIN: Pathfinder Number Test-Total Time (attention and psychomotor function [A/P]), Buschke Selective Reminding Test-Sum Recall (learning and memory [L/M]), and Sustained Working Memory Test-Overall Mid-Day Score (executive and frontal-lobe function [E/F])

Results: The primary neurocognitive analyses showed a difference between groups for only the E/F variable at the 2 month CPAP visit, but no difference at the 6 month CPAP visit or for the A/P or L/M variables at either the 2 or 6 month visits. When stratified by measures of OSA severity (AHI or oxygen saturation parameters), the primary E/F variable and one secondary E/F neurocognitive variable revealed transient differences between study arms for those with the most severe OSA. Participants in the active CPAP group had a significantly greater ability to remain awake whether measured subjectively by the Epworth Sleepiness Scale or objectively by the maintenance of wakefulness test.

Conclusions: CPAP treatment improved both subjectively and objectively measured sleepiness, especially in individuals with severe OSA (AHI > 30). CPAP use resulted in mild, transient improvement in the most sensitive measures of executive and frontal-lobe function for those with severe disease, which suggests the existence of a complex OSA-neurocognitive relationship.

Clinical trial information: Registered at clinicaltrials.gov. Identifier: NCT00051363.

Citation: Kushida CA; Nichols DA; Holmes TH; Quan SF; Walsh JK; Gottlieb DJ; Simon RD; Guilleminault C; White DP; Goodwin JL; Schweitzer PK; Leary EB; Hyde PR; Hirshkowitz M; Green S; McEvoy LK; Chan C; Gevins A; Kay GG; Bloch DA; Crabtree T; Demen WC. Effects of continuous positive airway pressure on neurocognitive function in obstructive sleep apnea patients: the Apnea Positive Pressure Long-term Efficacy Study (APPLES). SLEEP 2012;35(12):1593-1602.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Participant flow diagram. Study visits included: (1) Clinical Evaluation (CE) included informed consent, baseline testing and screening, and a medical examination by a study physician; (2) Training Sessions 1 and 2 (TS) consisted of neurocognitive test training, screening, and administration of psychological tests; (3) Diagnostic Polysomnography (PSG) Visit (DX PSG Visit) involved an overnight diagnostic sleep study, questionnaires, maintenance of wakefulness test (MWT), and the neurocognitive test battery; (4) CPAP Titration Visit (CT) included administration of questionnaires and an overnight CPAP titration PSG study conducted for both active and sham CPAP group participants to determine the optimal CPAP pressure for those in the active CPAP group; (5) CPAP Set-up Visit provided the participant with the active or sham CPAP device following the CPAP titration visit; (6) Two Month Post-CPAP Follow-Up Visit (2M CPAP Visit) represented a follow-up overnight CPAP titration PSG study, with questionnaires, psychological tests, MWT, and neurocognitive test battery; (7) Four Month Post-CPAP Follow-Up Visit (4M CPAP Visit) consisted of questionnaires and a follow-up appointment with a study physician that included a physical examination and discussion of CPAP adherence, protocol compliance, safety issues, and medication changes; (8) Six Month Post-CPAP Follow-Up Visit (6M CPAP Visit) used the same protocol as the 2M-CPAP Visit; (9) Additional Follow-Up Visit allowed the participant to discuss any issues or problems; (10) Exit Interview gave the participant an opportunity to initiate other OSA treatment options. ‡Excluded: participant removed from study “pre-randomization” due to exclusion criteria (e.g., taking exclusionary medication); Withdrawn: participant quit study “pre-randomization” due to participant's choice (e.g., too busy); Dropped: participant quit study “post-randomization” due to a participant-initiated decision (e.g., did not wish to continue with protocol); Disqualified: participant removed from study “post-randomization” due to a physician-initiated decision based on medical/safety reasons (e.g., following SAE based on opinion of Physician-Observer). All participants who dropped post-randomization were asked to continue with participant visits, even if they had discontinued therapy, based on our intention-to-treat study design. Participants who were disqualified for a medical/safety reason were asked to continue participant visits only after approval by the Site Director. On-Treatment: participant completed visits on originally assigned treatment condition; On-Study: participant completed visits, but may or may not be on originally assigned treatment condition.
See this image and copyright information in PMC

Comment in

  • CPAP or placebo-effect?
    Schwartz SW, Cimino CR, Anderson WM. Schwartz SW, et al. Sleep. 2012 Dec 1;35(12):1585-6. doi: 10.5665/sleep.2218. Sleep. 2012. PMID: 23204598 Free PMC article. No abstract available.
  • CPAP and Cognition in OSA (APPLES).
    Berlowitz DJ, Shafazand S. Berlowitz DJ, et al. J Clin Sleep Med. 2013 May 15;9(5):515-6. doi: 10.5664/jcsm.2682. J Clin Sleep Med. 2013. PMID: 23674945 Free PMC article. No abstract available.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Li C, Ford ES, Zhao G, Croft JB, Balluz LS, Mokdad AH. Prevalence of self-reported clinically diagnosed sleep apnea according to obesity status in men and women: National Health and Nutrition Examination Survey, 2005-2006. Prev Med. 51:18���23. - PubMed
    1. Sullivan CE, Issa FG, Berthon-Jones M, Eves L. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet. 1981;1:862–5. - PubMed
    1. Kushida CA, Nichols DA, Quan SF, et al. The Apnea Positive Pressure Long-term Efficacy Study (APPLES): rationale, design, methods, and procedures. J Clin Sleep Med. 2006;2:288–300. - PubMed
    1. American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep. 1999;22:667–89. - PubMed
    1. Krieger J, Kurtz D, Petiau C, Sforza E, Trautmann D. Long-term compliance with CPAP therapy in obstructive sleep apnea patients and in snorers. Sleep. 1996;19(9 Suppl):S136–43. - PubMed

SECTION 10. REFERENCES

    1. Kushida CA, Kuo T, McEvoy L, Gevins A, Guilleminault C, Dement WC. Apnea Positive Pressure Long-Term Efficacy Study (APPLES): Preliminary Studies. Sleep. 2004;27(Supplement):A181–182.
    1. Krieger J, Kurtz D, Petiau C, Sforza E, Trautmann D. Long-term compliance with CPAP therapy in obstructive sleep apnea patients and in snorers. Sleep. 1996 Nov 19;(9 Suppl):S136–143. - PubMed
    1. McArdle N, Devereux G, Heidarnejad H, Engleman HM, Mackay TW, Douglas NJ. Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med. 1999;159(4 Pt 1):1108–14. - PubMed
    1. Engleman HM, Kingshott RN, Martin SE, Douglas NJ. Cognitive function in the sleep apnea/hypopnea syndrome (SAHS) Sleep. 2000;23(Suppl 4):S102–108. - PubMed
    1. Bedard MA, Montplaisir J, Richer F, Rouleau I, Malo J. Obstructive sleep apnea syndrome: pathogenesis of neuropsychological deficits. J Clin Exp Neuropsychol. 1991;13:950–64. - PubMed

Publication types

Associated data